Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Oct 3;4(9):860-862.
doi: 10.1016/j.jdcr.2018.06.012. eCollection 2018 Oct.

Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series

Affiliations
Case Reports

Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series

Kathryn A Arnold et al. JAAD Case Rep. .
No abstract available

Keywords: BSA, body surface area; IGA, Investigator's Global Assessment; TCS, topical corticosteroid; atopic dermatitis; dupilumab; topical corticosteroids; topical steroid withdrawal.

PubMed Disclaimer

References

    1. Dhossche J., Simpson E., Hajar T. Topical corticosteroid withdrawal in a pediatric patient. J Am Acad Dermatol Case Rep. 2017;3(5):420–421. - PMC - PubMed
    1. Fukaya M., Sato K., Sato M. Topical steroid addiction in atopic dermatitis. Drug Healthc Patient Saf. 2014;6:131–138. - PMC - PubMed
    1. Sheary B. Topical corticosteroid addiction and withdrawal- An overview for GPs. Aust Fam Physician. 2016;45(6):386–388. - PubMed
    1. Hajar T., Leshem Y.A., Hanifin J.M. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72(3):541–549. - PubMed
    1. Rapaport M.J., Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol. 2003;21:201–214. - PubMed

Publication types

LinkOut - more resources